Exmed Investments Limited 13179293 true 2024-03-01 2025-02-28 2025-02-28 Digita Accounts Production Advanced 6.30.9574.0 true C Bamford J Parekh S Patel 13179293 2024-03-01 2025-02-28 13179293 2025-02-28 13179293 core:ShareCapital 2025-02-28 13179293 bus:FRS102 2024-03-01 2025-02-28 13179293 bus:AuditExempt-NoAccountantsReport 2024-03-01 2025-02-28 13179293 bus:FullAccounts 2024-03-01 2025-02-28 13179293 bus:RegisteredOffice 2024-03-01 2025-02-28 13179293 bus:Director1 2024-03-01 2025-02-28 13179293 bus:Director2 2024-03-01 2025-02-28 13179293 bus:Director3 2024-03-01 2025-02-28 13179293 bus:EntityNoLongerTradingButTradedInPast 2024-03-01 2025-02-28 13179293 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 13179293 countries:EnglandWales 2024-03-01 2025-02-28 13179293 2024-02-29 13179293 core:ShareCapital 2024-02-29 iso4217:GBP

Registration number: 13179293

Exmed Investments Limited
Annual Report and Unaudited Financial Statements
for the Year Ended 28 February 2025

Exmed Investments Limited

Contents

Balance Sheet | 1
Notes to the Unaudited Financial Statements | 2

Exmed Investments Limited

(Registration number: 13179293)
Balance Sheet as at 28 February 2025

| Note | 2025 £ | 2024 £
Current assets |  |  |
Cash at bank and in hand |  | 9 | 9
Capital and reserves |  |  |
Called up share capital |  | 9 | 9
Shareholders' funds |  | 9 | 9

For the financial year ending 28 February 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 17 September 2025 and signed on its behalf by:

J Parekh
Director

S Patel
Director

Exmed Investments Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2025

1 | General information

The company is a incorporated in England and Wales. The company was dormant and has not traded during the year.

The address of its registered office is:
130 Duke Street
St. Helens
WA10 2JL
England

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
For the year ended 28 February 2025, the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
The members also have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies..

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.